Hint mode is switched on Switch off
For swift navigation between sections

Organization: Par Pharmaceutical Companies
LEI 549300GLBA6FLQZ70X71

Organization name
Par Pharmaceutical Companies, Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
-

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is in the business of developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States. 

Awards

Documentation

IFRS/US GAAP reports

2015
2014
Authorization required
You need to request access

Stocks

Latest issues

Bond debt by currency

Codes

  • LEI
    549300GLBA6FLQZ70X71
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0000878088

Credit and ESG Ratings

Macroeconomic Indicators - Par Pharmaceutical Companies

Registration is required to get access.